Characteristics of Out-of-Care Patients Who Required a Referral for Re-engagement Services by Public Health Bridge Counselors Following a Brief Clinic-Based Retention Intervention

  • Nada Fadul
  • Sarah J. Willis
  • Jenna Donovan
  • Aimee Wilkin
  • Amy Durr Heine
  • Anna LeViere
  • Ciarra Dortche
  • Evelyn Byrd Quinlivan
Original Paper

Abstract

The NC-LINK Project initiated both clinic-based retention services and state public health bridge counselor-based (SBCs) re-engagement services to retain and re-engage people living with HIV infection (PLWH) in care. The goal of this project is to compare efforts between clinic-based retention and SBC re-engagement services to determine whether patients are more or less likely to remain in HIV care services. Clinic appointment data were used to identify patients who were last seen more than 6–9 months prior. Patients either received clinic-based retention services only or were subsequently referred to the SBC re-engagement intervention if the retention services were unsuccessful. The frequency of re-engagement in care (180 days) and HIV suppression (VLS, within 1 year) was examined for patients in these two groups. The SBC group was less likely to have VLS at the visit prior to referral (adjusted OR 2.04, 95% CI 1.53, 2.72). Patients who were referred to the SBC were less likely to re-engage in care within 180 days as compared to those who received clinic-based retention services only (adjusted OR 0.29, 95% CI 0.21, 0.41).

Keywords

Retention in care HIV care Out-of-care Re-engagement Patient care 

Notes

Acknowledgements

This project was supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under Systems Linkages for Access to Care Initiative H97HA22695. This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government. This study was conducted with the approval of the University & Medical Center Institutional Review Board at East Carolina University. The program was implemented as clinical care and did not require written consent. The authors also acknowledge the clinic staff, providers, and patients for their invaluable contributions to this research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Health Resources and Services Administration.

Author Contributions

All authors have contributed to the manuscript work, analysis, writing or editing and accept responsibility for publication. The authors also acknowledge the clinic staff, providers, and patients for their invaluable contributions to this research.

Compliance with Ethical Standards

Conflict of interest

None of the authors have conflicts of interest to report.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical Considerations for Animal Research: this article does not contain any studies with animals performed by any of the authors.

References

  1. 1.
    Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Dombrowski JC, Kitahata MM, Van Rompaey SE, Crane HM, Mugavero MJ, Eron JJ, et al. High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010. J Acquir Immune Defic Syndr. 2013;63(3):299–306.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301(22):2380–2.CrossRefPubMedGoogle Scholar
  4. 4.
    Mugavero MJ, Amico KR, Westfall AO, Crane HM, Zinski A, Willig JH, et al. Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J Acquir Immune Defic Syndr. 2012;59(1):86–93.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Shah M, Risher K, Berry SA, Dowdy DW. The epidemiologic and economic impact of improving HIV testing, linkage, and retention in care in the United States. Clin Infect Dis. 2016;62(2):220–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Giordano TP. Retention in HIV care: what the clinician needs to know. Top Antivir Med. 2011;19(1):12–6.PubMedGoogle Scholar
  7. 7.
    Mugavero MJ, Westfall AO, Cole SR, Geng EH, Crane HM, Kitahata MM, et al. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis. 2014;59(10):1471–9.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Tripathi A, Youmans E, Gibson JJ, Duffus WA. The impact of retention in early HIV medical care on viro-immunological parameters and survival: a statewide study. AIDS Res Hum Retroviruses. 2011;27(7):751–8.CrossRefPubMedGoogle Scholar
  9. 9.
    The Office of National AIDS Policy. National HIV/AIDS strategy for the United States: updated to 2020. 2015. https://www.aids.gov/federal-resources/national-hiv-aids-strategy/nhas-update.pdf. Accessed 19 Oct 2016.
  10. 10.
    Williams B, Amico KR, Konkle-Parker D. Qualitative to assessment of barriers and facilitators to HIV treatment. J Assoc Nurses AIDS Care. 2011;22(4):307–12.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Whetten K, Leserman J, Whetten R, Ostermann J, Thielman N, Swartz M, et al. Exploring lack of trust in care providers and the government as a barrier to health service use. Am J Public Health. 2006;96(4):716–21.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Berger MB, Sullivan KA, Parnell HE, Keller J, Pollard A, Cox ME, et al. Barriers and facilitators to retaining and reengaging HIV clients in care: a case study of North Carolina. J Int Assoc Provid AIDS Care. 2015;15:486–93.CrossRefPubMedGoogle Scholar
  13. 13.
    Reif SS, Whetten K, Wilson ER, McAllaster C, Pence BW, Legrand S, et al. HIV/AIDS in the Southern USA: a disproportionate epidemic. AIDS Care. 2014;26(3):351–9.CrossRefPubMedGoogle Scholar
  14. 14.
    North Carolina Department of Health and Human Services. HIV continuum of care in North Carolina reported HIV case data. 2014. http://epi.publichealth.nc.gov/cd/stds/figures/factsheet_HIV_continuum_of_care_2014.pdf. Accessed 19 Oct 2016.
  15. 15.
    Keller J, Heine A, LeViere AF, Donovan J, Wilkin A, Sullivan K, et al. HIV patient retention: the implementation of a North Carolina clinic-based protocol. AIDS Care. 2017;29(5):627–31.  https://doi.org/10.1080/09540121.2016.1226478.CrossRefPubMedGoogle Scholar
  16. 16.
    Swygard H, Sena AC, Mobley V, Clymore J, Sampson LA, Glenn K, et al. Implementation of a statewide team to facilitate linkage and re-engagement in HIV care in North Carolina. N C Med J. 2016 (In press).Google Scholar
  17. 17.
    Seña AC, Donovan J, Swygard H, Clymore J, Mobley V, Sullivan K, et al. The North Carolina HIV bridge counselor program: outcomes from a statewide level intervention to link and reengage HIV-infected persons in care in the South. J Acquir Immune Defic Syndr. 2017;76(1):e7–e14.  https://doi.org/10.1097/QAI.0000000000001389.CrossRefPubMedGoogle Scholar
  18. 18.
    Health Resources and Services Administration. CAREWare. 2016. http://hab.hrsa.gov/program-grants-management/careware. Accessed 19 oct 2016.
  19. 19.
    Milberg JA. Development, use, and integration of a nationally-distributed HIV/AIDS electronic health information system. J Am Med Inform Assoc. 2016;23:1190–4.CrossRefPubMedGoogle Scholar
  20. 20.
    Firth CL, Schafer SD, Greene K. Monitoring retention in care: using multiple laboratory tests as an indicator for HIV medical care. AIDS Care. 2014;26(12):1546–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Muthulingam D, Chin J, Hsu L, Scheer S, Schwarcz S. Disparities in engagement in care and viral suppression among persons with HIV. J Acquir Immune Defic Syndr. 2013;63(1):112–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Eaton EF, Saag MS, Mugavero M. Engagement in human immunodeficiency virus care: linkage, retention, and antiretroviral therapy adherence. Infect Dis Clin N Am. 2014;28(3):355–69.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Nada Fadul
    • 1
  • Sarah J. Willis
    • 2
  • Jenna Donovan
    • 3
  • Aimee Wilkin
    • 4
  • Amy Durr Heine
    • 5
  • Anna LeViere
    • 5
  • Ciarra Dortche
    • 1
  • Evelyn Byrd Quinlivan
    • 5
  1. 1.Division of Infectious Diseases and International Travel HealthEast Carolina UniversityGreenvilleUSA
  2. 2.Center for Health Policy and Inequalities ResearchDuke UniversityDurhamUSA
  3. 3.NC Department of Health and Human ServicesCommunicable Disease BranchRaleighUSA
  4. 4.Section on Infectious DiseasesWake Forest School of MedicineWinston-SalemUSA
  5. 5.Institute for Global Health and Infectious DiseasesUniversity of North Carolina at Chapel HillChapel HillUSA

Personalised recommendations